comparemela.com

Latest Breaking News On - Nervgen - Page 3 : comparemela.com

DGAP-News: NervGen Pharma: Has The Controversy Around Falsified Alzheimer s Research Impacted The Path To Finding The Cure?

DGAP-News: NervGen Pharma Has The Controversy Around Falsified Alzheimer's Research Impacted The Path To Finding The Cure? 08.09.2022 / 22:47 CET/CEST The issuer is solely responsible

United statesMatthew schraggNervgen pharmaPaul brennanNancy thompsonSylvain lesnNational institute of healthEisai coBiogen incNervgen pharma corpDistribution servicesControversy around falsified alzheimer researchPfizer incAlzheimer research go fromNews serviceNational institute

NervGen Pharma Corp : NervGen Pharma Grants Stock Options

Vancouver, British Columbia (Newsfile Corp. - July 15, 2022) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a clinical stage biotech company dedicated to developing

United kingdomBritish columbiaNancy thompsonHuitt traceyCorporate communicationsBritish columbia newsfile corpRegulation services providerNervgen pharma corpVenture exchangeGen pharmaVorticom public

NervGen Pharma Corp : NervGen Pharma Closes US$15MM Private Placement and Appoints Dr Adam Rogers to Board of Directors

Vancouver, British Columbia (Newsfile Corp. - July 14, 2022) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" the "Company"), a clinical stage biotech company dedicated to developing a first-in-class

United statesUnited kingdomBritish columbiaHemera biosciencesAdam rogersBill adamsSuzanne adamsHuitt traceyEngland eye centerEmory university board of trusteesCompanya common shareNervgen pharma corpFamily incTufts medical center bostonEmory school of medicineRegulation services provider

NervGen Pharma Corp : NervGen Pharma Grants Stock Options

Vancouver, British Columbia (Newsfile Corp. - May 31, 2022) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a clinical stage biotech company dedicated to developing a

United kingdomBritish columbiaNancy thompsonHuitt traceyLinkedin nervgen pharma corpCorporate communicationsBritish columbia newsfile corpRegulation services providerNervgen pharma corpVenture exchangeGen pharmaVorticom public

NervGen Pharma Corp : NervGen Pharma Grants Stock Options

Vancouver, British Columbia (Newsfile Corp. - April 6, 2022) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a clinical stage biotech company dedicated to developing

United kingdomBritish columbiaNancy thompsonHuitt traceyLinkedin nervgen pharma corpCorporate communicationsBritish columbia newsfile corpRegulation services providerNervgen pharma corpVenture exchangeGen pharmaVorticom public

vimarsana © 2020. All Rights Reserved.